Our mission is to enhance women’s lives by providing clinically proven, non-invasive products to improve female Stress Urinary Incontinence

Viveve aspires to be the leader
in the treatment of female
Stress Urinary Incontinence

The internationally patented Viveve® System incorporates Cryogen-cooled Monopolar Radiofrequency (CMRF) technology to uniformly provide an endovaginal treatment that is non-ablative.

What Sets Us Apart?


Clinical Evidence

Conducting clinical trials to prove safety and efficacy of our technology is foundational to Viveve. Large, multicenter, randomized, and blinded clinical trials conducted following U.S. and International regulatory agency requirements is Viveve’s tradition. Sound clinical studies provide evidence that demonstrates the effectiveness of a medical device to safely treat a specific medical condition.


Enthusiastic Acceptance Worldwide

The Viveve System is currently used by physicians and women’s healthcare practitioners in the U.S. and Asian Pacific Countries. In the United States, the Viveve System is approved for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances include its use for vaginal laxity and/or improvement of sexual function and/or improvement of Stress Urinary Incontinence in women.

badge-check (1)

Internationally Patented

Viveve has a strong, protected intellectual property portfolio of U.S. and International patents for its Cryogen-cooled Monopolar Radiofrequency (CMRF) dual energy technology platform and its use in vaginal tissue. Recently, a new U.S. Method Patent for Stress Urinary Incontinence was issued to further strengthen the Company’s IP portfolio.

Interested in learning more about Viveve’s products?

Learn More About Viveve’s Products

Product Indications

Viveve System
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.
Viveve Solutions
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States. The InControl Products (InToneMV) is indicated for the treatment of all forms of urinary incontinence in the United States and Canada.